John Bell

Researcher
  • BioCanRX
  • Ottawa Hospital Research Institute
  • University of Ottawa
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • All Cancers

    Canadian Oncolytic Virus Consortium (COVCo)

    In a perfect world, there would be no cancer. And if there were, patients would be able to stimulate their own immune system to destroy tumours with a virus designed to kill only cancerous cells and l...

    Read More
  • Completed
    All Cancers

    Canadian oncolytic virus consortium - I

    In a perfect world, there would be no cancer. And if there were, patients would be able to stimulate their own immune system to destroy tumours with a virus designed to kill only cancerous cells and l...

    Read More

Related News & Events

  • Research Highlight|May 14, 2019

    TFRI-funded scientists publish snapshot on oncolytic viruses in top scientific journal

    Members of a long-standing TFRI team focused on developing cancer-killing viruses have published a snapshot article summarizing this promising area of...

  • Research Highlight|September 10, 2018

    Scientists use protein found in mosquito virus to suppress RNAi pathway, opening door to make oncolytic viruses more effective

    By using a protein from a virus first found in Japanese mosquitoes in the 1950s, TFRI-funded researchers have discovered a new way to bypass antiviral...

  • TFRI News|February 08, 2018

    2017 Marathon of Hope Lecture Series

    As part of its 10th anniversary celebration, TFRI presented a session titled The Marathon of Hope Lecture Series at the Canadian Cancer Research Confe...

  • Research Highlight|January 03, 2018

    New study shows viruses and checkpoint inhibitors work together to cure resistant breast cancer in mice

    A new study led by TFRI-funded researchers at The Ottawa Hospital (TOH) and the University of Ottawa suggests that a combination of two immunotherapie...

  • TFRI News|September 06, 2017

    Four premier TFRI investigators will present Marathon of Hope talks at CCRC

    TFRI is pleased to announce that it will be presenting a concurrent session (D6 in program) at the upcoming Canadian Cancer Research Conference featur...

  • Press Release|September 05, 2017

    Three 2017 PPG awards announced for cutting-edge projects in leukemia, oncolytic viruses, nanoparticle imaging

    The Terry Fox Research Institute has invested nearly $21.5-million to renew three 2017 Terry Fox New Frontiers Program Project Grants (PPGs).

  • Research Highlight|May 24, 2017

    Complement inhibitors decrease neutralization of some oncolytic viruses, increase treatment efficacy

    The use of oncolytic viruses to stimulate a patient’s immune system as well as directly kill tumour cells is a novel approach to eradicating cancer, b...

  • In the Media|July 10, 2015

    Canadian study to use two cancer-fighting viruses in world first

    Ontario researchers have launched the first clinical trial that will use two, custom-made, cancer-fighting viruses to stimulate the immune system into...

  • Research Highlight|July 10, 2015

    Cancer patients treated in world-first clinical trial of viral therapy

    Terry Fox-funded researchers are key members of a Canadian team to have launched the world’s first clinical trial of a new therapy that uses a combina...

  • All News & Events